Manufacturing
-
How Biologic Therapeutics Are Developed
8/26/2021
Scientists are harnessing the power of cellular machinery to produce therapeutic biologics that can target specific conditions. Learn about the process of developing a biologic treatment.
-
Efficient-Pro Medium And Feed (Why Choose Pro)
6/27/2025
Discover an animal-origin-free and chemically defined medium and feed system solution designed to revolutionize your workflow.
-
How MilliporeSigma Promotes Quality And Risk Reduction
10/20/2021
Learn how MilliporeSigma’s new facility was built with quality and risk reduction at the top of mind and its experts have the experience to support large-scale programs through commercialization.
-
Reimagine Sustainability In Bioprocessing
4/16/2025
Achieving sustainability in bioprocessing labs presents distinct challenges. Learn how to reduce your environmental footprint while maintaining efficiency and avoiding extensive re-validation efforts.
-
LC/MS Method For Measurement In Human Plasma
2/17/2025
According to the researchers, this plasma-based measurement has the potential to serve as a critical pharmacodynamic biomarker, facilitating the assessment of novel therapeutic approaches.
-
Single-Use Filter Transfer Sets Ready For Final Filling
9/6/2022
Our industry-first, preconfigured filter transfer set for final filling arrives up to 80% faster, is PUPSIT-optimized, sterile and ready to use.
-
Simplifying Bioprocess Data Collection
2/17/2023
Centralized bioprocess data collection and aggregation lowers the risk of data loss during any manual retrieval process. Discover a solution that helps you meet data storage and reporting requirements.
-
Elutriation And Washing In One System
6/21/2022
This elutriation and wash system can be used to initiate a wide number of cell therapy manufacturing processes such as CAR-T, dendritic cells, TIL, and IPSC-derived therapy.
-
How To Select Your DSP Chromatography Technology?
6/7/2021
Making the switch from single batch to multi-column chromatography can dramatically reduce resin utilization, costs and eliminate bottlenecks without sacrificing quality. This animated feature compares the traditional, single batch approach to a multi-column alternative for mAb capture.
-
Executive Roundtable: Cell Therapy Predictions For 2025 And Beyond
12/17/2024
In this executive roundtable discussion, Bioprocess Online editor Tyler Menichiello is joined by CEO, co-founder, and president of Ossium Health, Kevin Caldwell, CSO of FibroBiologics, Hamid Khoja, Ph.D., and president and acting CEO of Triumvira Immunologics, Rob Williamson. The panelists share their predictions and thoughts on the industry’s direction heading into 2025. They cover manufacturing trends (noting opportunities for improvements in cell therapy manufacturing), AI adoption, regulatory concerns, and the potentially challenging funding environment ahead.